Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia.
Bruna LosJessica Bassani BorgesVictor Fernandes OliveiraRenata Caroline Costa FreitasCarolina Dagli HernandezRaul Hernandes BortolinRodrigo Marques GonçalvesAndre Arpad FaludiAlice Cristina RodriguesGisele Medeiros BastosCinthia Elim JannesAlexandre da Costa PereiraRosario Dominguez Crespo HirataMario Hiroyuki HirataPublished in: Epigenomics (2021)
Aim: Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions were explored in patients with familial hypercholesterolemia (FH). Materials & methods: PCSK9 3'UTR variants were identified by exon-targeted gene sequencing. Functional effects of 3'UTR variants and mRNA-miRNA interactions were analyzed using in silico and in vitro studies in HEK293FT and HepG2 cells. Results: Twelve PCSK9 3'UTR variants were detected in 88 FH patients. c.*75C >T and c.*345C >T disrupted interactions with miR-6875, miR-4721 and miR-564. Transient transfection of the c.*345C >T decreased luciferase activity in HEK293FT cells. miR-4721 and miR-564 mimics reduced PCSK9 expression in HepG2 cells. Conclusion: PCSK9 c.*345C >T has a possible role as loss-of-function variant. miR-4721 and miR-564 downregulate PCSK9 and may be useful to improve lipid profile in FH patients.
Keyphrases
- cell proliferation
- long non coding rna
- long noncoding rna
- copy number
- end stage renal disease
- poor prognosis
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- peritoneal dialysis
- induced apoptosis
- genome wide
- transcription factor
- patient reported outcomes
- brain injury
- signaling pathway
- cell cycle arrest
- molecular docking
- pi k akt
- molecular dynamics simulations